| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1112858405 |
| P356 | DOI | 10.1038/S41598-019-40973-0 |
| P932 | PMC publication ID | 6424956 |
| P698 | PubMed publication ID | 30890722 |
| P50 | author | Ernest Giralt i Lledó | Q19288781 |
| P2093 | author name string | Meritxell Teixidó | |
| Roger Prades | |||
| Sonia Ciudad | |||
| Bernat Guixer | |||
| Pol Arranz-Gibert | |||
| P2860 | cites work | Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow. | Q51782381 |
| Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides | Q56390180 | ||
| Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding? | Q57041094 | ||
| Drug transport across the blood-brain barrier | Q57677287 | ||
| HAI Peptide and Backbone Analogs-Validation and Enhancement of Biostability and Bioactivity of BBB Shuttles | Q60301461 | ||
| Detection of secondary amines on solid phase | Q70802482 | ||
| A novel approach using functional peptides for efficient intestinal absorption of insulin | Q79707015 | ||
| Iron metabolism in the CNS: implications for neurodegenerative diseases | Q38118885 | ||
| In vitro models of the blood-brain barrier for the study of drug delivery to the brain | Q38196915 | ||
| Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review | Q38200847 | ||
| Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells. | Q38895031 | ||
| Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals | Q38988688 | ||
| Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery | Q39252767 | ||
| Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier | Q39594745 | ||
| Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. | Q40639360 | ||
| Receptor mediated uptake of peptides that bind the human transferrin receptor | Q40817617 | ||
| N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles | Q43156566 | ||
| Oxyma: an efficient additive for peptide synthesis to replace the benzotriazole-based HOBt and HOAt with a lower risk of explosion. | Q45941235 | ||
| Peptides as skin penetration enhancers: mechanisms of action | Q46405335 | ||
| Lipid bilayer crossing--the gate of symmetry. Water-soluble phenylproline-based blood-brain barrier shuttles | Q48168586 | ||
| Applying the retro-enantio approach to obtain a peptide capable of overcoming the blood-brain barrier | Q48344384 | ||
| High throughput artificial membrane permeability assay for blood-brain barrier | Q48349894 | ||
| Transferrin receptor on endothelium of brain capillaries | Q48602638 | ||
| A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells | Q28539764 | ||
| Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers | Q33201105 | ||
| Quantification of the cellular uptake of cell-penetrating peptides by MALDI-TOF mass spectrometry | Q33216270 | ||
| Mass spectrometry and protein analysis | Q33239890 | ||
| A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry | Q33280932 | ||
| Toward an optimal blood-brain barrier shuttle by synthesis and evaluation of peptide libraries | Q33356194 | ||
| COMU: a safer and more effective replacement for benzotriazole-based uronium coupling reagents | Q33484799 | ||
| Transferrin and transferrin receptor function in brain barrier systems | Q33847801 | ||
| Modelling of the blood-brain barrier in drug discovery and development. | Q34005458 | ||
| Strategies and challenges for the next generation of therapeutic antibodies | Q34111699 | ||
| Bioisosterism: A Rational Approach in Drug Design | Q34114437 | ||
| Multiplexed evaluation of serum and CSF pharmacokinetics of brain-targeting single-domain antibodies using a NanoLC-SRM-ILIS method | Q34476523 | ||
| A novel platform for engineering blood-brain barrier-crossing bispecific biologics | Q35214538 | ||
| Cell culture-based models for intestinal permeability: a critique | Q36062695 | ||
| Structure-brain exposure relationships | Q36688879 | ||
| Organ targeting in vivo using phage display peptide libraries | Q36795550 | ||
| Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformers. | Q36813985 | ||
| 2B-Trans technology: targeted drug delivery across the blood-brain barrier | Q37120457 | ||
| Delivering quantum dots into cells: strategies, progress and remaining issues | Q37287382 | ||
| Three-dimensional pharmacophore methods in drug discovery | Q37615315 | ||
| Recent progress in fluorescent and colorimetric chemosensors for detection of amino acids | Q37907875 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4875 | |
| P577 | publication date | 2019-03-19 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles-Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models | |
| P478 | volume | 9 |
Search more.